Clinical Trial Update: Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients [NA]

View source ↗

Summary

Clinical trial update describes recruitment for a study evaluating mesenchymal stem cell supernatant to prevent and treat skin and mucosal injury in hematology …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Mucositis
• Hematopoietic Stem Cell Transplantation
• Mucositis
• Radiation-induced Mucositis

Drugs mentioned

• Mesenchymal stem cell supernatant (mesenchymal stem cell conditioned medium)

Snippet

Sponsor: The General Hospital of Western Theater Command | Conditions: Mucositis, Hematopoietic Stem Cell Transplantation | NA | Status: RECRUITING